2O9 vs GS71: Side-by-Side Comparison
Compare RENALYTIX PLC LS-0025 (2O9) and GSK plc (GS71) side by side: market cap EUR 8.74M vs EUR 91.51B. Financials, growth and model signals on Bullrun.
| Metric | 2O9 | GS71 |
|---|---|---|
| Company | RENALYTIX PLC LS-0025 | GSK plc |
| Country / Exchange | United Kingdom · F | United Kingdom · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Drug Manufacturers - General |
| Market cap | EUR 8.74M | EUR 91.51B |
| P/E ratio | — | 13.8 |
| Dividend yield | — | 3.40% |
| Valuation model | — | 30.7% undervalued |
| Revenue (latest FY) | — | GBP 32.67B |
| Revenue growth YoY | — | +4.1% |
| Net income | — | GBP 6.29B |
| Gross margin | — | 72.4% |
| Diluted EPS | — | 1.39 |